Related Experiment Video

Updated: Jun 25, 2025

Demonstration of Heterologous Complexes formed by Golgi-Resident Type III Membrane Proteins using Split Luciferase Complementation Assay
05:28

Demonstration of Heterologous Complexes formed by Golgi-Resident Type III Membrane Proteins using Split Luciferase Complementation Assay

Published on: September 10, 2020

2.3K

Enhanced Sampling Molecular Dynamics Simulations Reveal Transport Mechanism of Glycoconjugate Drugs through GLUT1

Zhuo Liu1, Xueting Cao1, Zhenyu Ma1

  • 1National Glycoengineering Research Center, Shandong University, Qingdao 266237, China.

International Journal of Molecular Sciences
|May 25, 2024
PubMed

Insights

Researchers explored how glucose transporters (GLUT1) interact with anticancer drugs. They discovered key residues regulating drug transport, offering insights for designing new GLUT1-targeted cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Glucose transporters, specifically GLUT1, are crucial for glucose uptake in humans.
  • Overexpressed GLUT1 in tumor cells makes it a key target for glycoconjugate anticancer drugs.
  • The precise interaction mechanisms between GLUT1 and these drugs are not well understood.

Purpose of the Study:

  • To investigate the thermodynamics and molecular interactions governing the transport of glucose and glycoconjugate drugs by GLUT1.
  • To elucidate the atomic-scale details of substrate recognition, transport, and release by GLUT1.
  • To identify key amino acid residues involved in regulating GLUT1-mediated transport of anticancer agents.

Main Methods:

  • All-atom molecular dynamics simulations were performed.
  • Steered and umbrella sampling techniques were utilized to analyze transport free energy profiles.
  • Specific interactions between GLUT1 and substrates (glucose, two glycoconjugate drugs) were characterized.

Main Results:

  • The study characterized interactions between GLUT1 and substrates throughout the transport process.
  • Key residues involved in substrate recognition, transport, and release were identified.
  • The free energy profiles for GLUT1 transporting glycoconjugate drugs were determined for the first time.
  • Residues H160 and W388 were identified as critical gates regulating drug transport via GLUT1.

Conclusions:

  • This research provides the first atomic-scale insights into the transport mechanism of glycoconjugate drugs by GLUT1.
  • The findings reveal specific residues and interactions crucial for GLUT1-mediated drug transport.
  • These insights will facilitate the rational design and discovery of novel GLUT1-targeted anticancer drugs.
Keywords:
GLUT1anticancer drugglycoconjugatemolecular dynamics simulationstransport mechanism

More Related Videos

Engineering Antiviral Agents via Surface Plasmon Resonance13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.3K
A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood06:28

A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood

Published on: August 12, 2016

16.6K

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.6K
Membrane Proteins01:30

Membrane Proteins

Plasma membranes have integral transmembrane proteins involved in facilitated transport. These proteins are collectively referred to as transport proteins, and they function as either channels for the material or as carriers themselves. Channel proteins have hydrophilic domains exposed to the intracellular and extracellular fluids and a hydrophilic channel through their core that provides a hydrated opening for solutes to pass through the membrane layers. Passage through the channel allows...
19.2K
Secondary Active Transport01:32

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
7.0K
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
2.8K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
365